Glenmark Pharmaceuticals Share Price

• Overview
• News
• Analysis
• Recos
• Financials
• Forecast
• Technicals
• Peers
• Shareholdings
• MF
• F&O
• Corp Actions
• About
• More
  • MF
  • F&O
  • Corp Actions
  • About
• EnglishEnglishहिन्दीગુજરાતીमराठीবাংলাಕನ್ನಡதமிழ்తెలుగు
  Rank 157 - ET 5002022 ranking

Glenmark Pharma News & Analysis

Glenmark Pharma Share Recommendations

Peer Comparison

Glenmark Pharma Shareholding Pattern

MF Ownership

• HDFC Mid-Cap Opportunities Direct-G

  Equity: Mid Cap

  4

  • 435.39

    Amount Invested (in Cr.)

  • 0.92%

    % of AUM

  • 0.00

    % Change (MoM basis)

• Aditya Birla SL Flexi Cap Direct-G

  Equity: Flexi Cap

  3

  • 368.14

    Amount Invested (in Cr.)

  • 2.13%

    % of AUM

  • 0.00

    % Change (MoM basis)

• Aditya Birla SL Mid Cap Direct-G

  Equity: Mid Cap

  2

  • 100.59

    Amount Invested (in Cr.)

  • 2.32%

    % of AUM

  • 0.00

    % Change (MoM basis)

Glenmark Pharma F&O Quote

Corporate Actions

About Glenmark Pharma

Glenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 24,139.49 Crore) operating in Pharmaceuticals sector. Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the year ending 31-Mar-2022.For the quarter ended 30-06-2023, the company has reported a Consolidated Total Income of Rs 3,422.47 Crore, up 2.67 % from last quarter Total Income of Rs 3,333.50 Crore and up 15.61 % from last year same quarter Total Income of Rs 2,960.44 Crore. Company has reported net profit after tax of Rs 173.13 Crore in latest quarter.The company’s top management includes Mr.Glenn Saldanha, Mr.V S Mani, Mrs.Cherylann Pinto, Mrs.B E Saldanha, Mr.Bernard Munos, Dr.Brian W Tempest, Mr.D R Mehta, Mr.Dipankar Bhattacharjee, Mr.Rajesh V Desai, Ms.Saira Ramasastry, Mr.Sridhar Gorthi, Mr.Harish Kuber. Company has Walker, Chandiok & Co.LLP as its auditors. As on 30-06-2023, the company has a total of 28.22 Crore shares outstanding. Show More

FAQs about Glenmark Pharma share

• 1. What is Glenmark Pharma share price and what are the returns for Glenmark Pharma share?
  Glenmark Pharma share price was Rs 855.50 as on 29 Sep, 2023, 03:57 PM IST. Glenmark Pharma share price was up by 10.11% based on previous share price of Rs 776.95. Glenmark Pharma share price trend:

  • Last 1 Month: Glenmark Pharma share price moved up by 13.08%
  • Last 3 Months: Glenmark Pharma share price moved up by 26.63%
  • Last 12 Months: Glenmark Pharma share price moved up 121.06%
  • Last 3 Years: Glenmark Pharma Share price moved up by 76.14%
• 2. Who are peers to compare Glenmark Pharma share price?
  Within Pharmaceuticals sector Glenmark Pharma, Ajanta Pharma Ltd., J B Chemicals & Pharmaceuticals Ltd., Laurus Labs Ltd., Ipca Laboratories Ltd., Aarti Industries Ltd., Gland Pharma Ltd., Natco Pharma Ltd., Alembic Pharmaceuticals Ltd., Suven Pharmaceuticals Ltd. and Piramal Pharma Ltd. are usually compared together by investors for analysis.
• 3. What's the market capitalization of Glenmark Pharma?
  Glenmark Pharma share has a market capitalization of Rs 24,139.49 Cr. Within Pharmaceuticals sector, it's market cap rank is 16.
• 4. What has been highest price of Glenmark Pharma share in last 52 weeks?
  Glenmark Pharma share price saw a 52 week high of Rs 880.00 and 52 week low of Rs 368.00.
• 5. How can I quickly analyze Glenmark Pharma stock?
  Glenmark Pharma share can be quickly analyzed on following metrics:

  • Stock's PE is 165.23
  • Price to Book Ratio of 2.46
  • Dividend Yield of 0.29
  • EPS (trailing 12 month) of Glenmark Pharma share is 5.18
• 6. Who are the key owners of Glenmark Pharma stock?
  • Promoter holding has not changed in last 9 months and holds 46.65 stake as on 30 Jun 2023
  • Domestic Institutional Investors holding have gone down from 10.68 (30 Sep 2022) to 8.9 (30 Jun 2023)
  • Foreign Institutional Investors holding has gone up from 23.14 (30 Sep 2022) to 25.51 (30 Jun 2023)
  • Other investor holding have gone down from 19.53 (30 Sep 2022) to 18.94 (30 Jun 2023)